Medical/Pharmaceuticals

Neurophet Supplies 'Neurophet AQUA' to Raffles Medical in Singapore

* Providing Neurophet AQUA capable of analyzing brain atrophy and white matter degeneration… Securing meaningful clinical reference SEOUL, South Korea, July 2, 2026 /PRNewswire/ -- Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain...

2026-07-02 21:00 1366

POMDOCTOR LIMITED Announces Strategic Upgrade Toward Infrastructure for Predictive Healthcare Data and Services

GUANGZHOU, China, July 2, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade, officially positioning the Company as a foundational infrastructure provider for predicti...

2026-07-02 20:00 1766

SK bioscience Launches AI-Powered Initiative to Reduce Uncertainty in Vaccine-Development Decisions

* SK bioscience was selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework. * SK bioscience, PATH, Slalom, and SK AX will jointly develop an AI-powered platform for evidence-based clinical development decision-making. * The project will supp...

2026-07-02 20:00 1491

Yidu Tech Achieves Its First Full-Year Profit: FY2026 Net Profit Reaches RMB 78.8 Million, with Positive Operating Cash Flow in the Second Half

BEIJING, July 2, 2026 /PRNewswire/ -- On July 2, Yidu Tech (02158.HK), a leading AI healthcare company, held its annual results presentation to review its financial performance for the fiscal year ended March 31, 2026 ("FY2026"). During the reporting period, the Company achieved its first full-ye...

2026-07-02 17:14 2370

Fosun International Garners Five Awards from Corporate Governance Asia

Chen Qiyu and Xu Xiaoliang, Co-CEOs of Fosun International win Asia's Best CEO fromCorporate Governance Asia Fosun International receives Sustainable Asia Award 2026, Best Environmental Responsibility Award and Best Corporate Communications Award HONG KONG, July 2, 2026 /PRNewswire/ -- On 30 Jun...

2026-07-02 12:43 2429

Insilico Medicine Announces Collaboration with Takeda to Advance Strategic AI Drug Discovery

Partnership to leverage Pharma.AI platform for novel drug candidates across Takeda's therapeutic areas CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico" HKEX:3696), a leader in clinical-stage generative AI for drug discovery, today announced a strategic collaboration a...

2026-07-02 10:16 1899

MORE YOUNG PEOPLE STRUGGLE WITH HAIR LOSS: REGAINE®* LEADS THE CHARGE FOR HAIR SCIENCE RESEARCH

* New findings show hair loss affecting more young people in APAC * Social media is driving earlier awareness of hair loss * REGAINE® reaffirms commitment to research and innovation to meet evolving hair loss landscape at the 14th World Congress of Hair Research (WCHR) * Study conducted by ...

2026-07-02 10:00 1937

MORE YOUNG PEOPLE STRUGGLE WITH HAIR LOSS: REGAINE®* LEADS THE CHARGE FOR HAIR SCIENCE RESEARCH

* New findings show hair loss affecting more young people in APAC * Social media is driving earlier awareness of hair loss * REGAINE® reaffirms commitment to research and innovation to meet evolving hair loss landscape at the 14th World Congress of Hair Research (WCHR) * Study conducted by ...

2026-07-02 10:00 2272

Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH

SUZHOU, China and MÖLNDAL, Sweden, July 2, 2026 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. (06938.HK), and its subsidiary Ribocure Pharmaceuticals AB (collectively referred to as "Ribo"), in collaboration with Madrigal Pharmaceuticals, Inc. (Madrigal, NASDAQ: MDGL) announce the successful...

2026-07-02 09:29 1701

Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC

SHANGHAI, July 1, 2026 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, HKEX code: 02256.HK) today announced that it has entered into a strategic collaboration agreement with AstraZeneca (LSE/STO/NYSE: AZN) to jointly advance the clinical development of a novel I...

2026-07-02 09:00 1824

Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases

CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–base...

2026-07-02 08:05 1729

NYSE Content Update: Mobility Global Marks First Day as Public Company

NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 1, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins...

2026-07-01 21:22 3501

FAIR PLAY MENARINI INTERNATIONAL AWARD: THE 30TH EDITION KICKS OFF

FLORENCE, Italy, July 1, 2026 /PRNewswire/ -- Florence opens its doors to the 30th Fair Play Menarini International Award. Today marks the opening of the event celebrating champions who have distinguished themselves not only through their sporting achievements, but also through respect, ethics, a...

2026-07-01 20:26 1611

STARMED Receives FDA 510(k) Clearance for a Benign Thyroid Nodule Ablation Indication

SEOUL, South Korea, July 1, 2026 /PRNewswire/ -- STARMED, a medical device company specialising in minimally invasive treatment technologies, has announced that it has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for a thyroid-specific indication (510(k) number: K2528...

2026-07-01 20:00 1910

Vitafoods Asia 2026: Science-Backed Botanicals and Next-Generation Probiotics Take Centre Stage

Leading Companies Present Science-Backed Solutions Addressing Antimicrobial Resistance, Digestive Health, and Wellness Through Advanced Probiotics and Clinical Botanicals BANGKOK, July 1, 2026 /PRNewswire/ -- As global healthcare confronts the urgent challenge of antimicrobial resistance, Vitafo...

2026-07-01 18:37 2187

PharmaResearch Accelerates REJURAN Cosmetics Expansion Across North and South America with Planned Acquisition of CG USA

Acquisition strengthens local manufacturing and logistics capabilities as REJURAN Cosmetics expands across Sephora, Amazon and Canada, with future growth across the Americas in view  SEOUL, South Korea, July 1, 2026 /PRNewswire/ -- PharmaResearch, the South Korea-based regenerative medicine comp...

2026-07-01 13:38 3343

Basecamp Research brings EDEN's antibiotic and vaccine design models to Claude Science

Scientists can now design potent antibiotics and rapidly prioritise vaccine targets through Claude Science, thanks to integration with Basecamp Research's EDEN models. LONDON and CAMBRIDGE, Mass., July 1, 2026 /PRNewswire/ -- Basecamp Research  today announced tha...

2026-07-01 01:00 1779

ALR Technologies Announces Strategic Acquisition of CGM Medical Technology for US$45 Million & 200M Shares

SINGAPORE, June 30, 2026 /PRNewswire/ -- ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical Technology Singapore Pte. Ltd. ("CGM Medical Singapore") and ass...

2026-06-30 23:26 3757

Pictor® Holdings Inc. Secures $7.5 Million Bridge Round to Accelerate Commercialization of Targeted Proteomic Platform

Investment brings Pictor's total capital raised to approximately $30 million, supporting expanded U.S. and international commercialization efforts CARLSBAD, Calif., June 30, 2026 /PRNewswire/ -- Pictor Holdings Inc., a global targeted proteomic platform company headquartered in Carlsbad, Califor...

2026-06-30 23:02 1781

Tsingke Biotech Hosts Shanghai Salon on Oligonucleotide Drugs, Spotlighting Next-Gen RNA Therapeutics

SHANGHAI, June 30, 2026 /PRNewswire/ -- Tsingke Biotech recently hosted the Oligonucleotide Drug Salon at the Hilton Shanghai Zhangjiang, bringing together experts from academia, biopharmaceutical companies, investment firms, and industry service organizations to discuss technological innovation,...

2026-06-30 22:17 2054
12345 ... 649